Skip to main content
. 2023 Nov 8;8:174. doi: 10.1038/s41541-023-00767-y

Table 4.

Model parameters estimated on Phase I participants by Pasin et al.16 and the new estimates obtained on pooled Phase I and Phase II data and considering adjustment for laboratory effects.

Parameter Meaning Phase I data Phase I & II data
Mean 95% CI Mean 95% CI
Fixed effects
δAb Antibody decay rate (day−1) 0.029 [0.027; 0.033]
Women 0.0251 [0.0223; 0.0283]
Men 0.0353 [0.0296; 0.0421]
log(2)/δAb Antibody half-life (days) 24 [22; 26]
Women 27.6 [24.5; 31.1]
Men 19.6 [16.4; 23.4]
δS SL ASCs decay rate (day−1) 0.231 [0.15; 0.36] 0.333 [0.326; 0.340]
log(2)/δS SL ASCs half-life (days) 3.0 [1.9; 4.7] 2.08 [2.04; 2.13]
δL LL ASCs decay rate (year−1) 3.16 × 10−4 [1.46; 7.03] × 10−4 1.25 × 10−4
log(2)/δL LL ASCs half-life (years) 6.0 [2.7; 13] 15.0
ϕS SL ASCs influx (EU/mL/day) 2755 [1852; 4100]
Mean Age (31.3 years) 3057 [2418; 3865]
FC ΔAge = + 1 yeara 0.934 [0.915; 0.954]
ϕL LL ASCs influx (EU/mL/day)
African part. 16.6 [13.7; 20.1] 10.2 [9.01; 11.4]
Eur. part. 70.7 [54.0; 92.7] 36.6 [27.3; 49.2]
α Scaling factor—lab effects
αfocus 1.04 [0.93; 1.16]
αQ2sol 1.00 [0.98; 1.02]
Random effects
ωϕS Sd of RE on ϕS 0.92 [0.83; 1.01] 0.84 [0.56; 1.13]
ωϕL Sd of RE on ϕL 0.85 [0.78; 0.92] 0.88 [0.81; 0.96]
ωδAb Sd of RE on δAb 0.30 [0.24; 0.36] 0.35 [0.29; 0.41]
Error model
σAb Sd of error model 0.10 [0.10; 0.10] 0.107 [0.101; 0.112]

CI confidence interval, EU ELISA units, Eur. European, FC fold change, LL ASCs long-lived antibody-secreting cells, Part. participants, RE random effects, SL ASCs short-lived antibody-secreting cells, Sd standard deviation.

aRepresents the multiplicative factor to apply to the value of ϕS, obtained for the mean age, for an increase in participant age of 1 year: ϕS(Mean Age + 1 year) = ϕS(Mean Age) × FC(ΔAge = +1). Therefore, the percentage of decrease of ϕS for a participant X years older than the mean age is given by 100×(1−FC(ΔAge = +1)X).